Sahasrabuddhe C G, Morgan J, Sharma S, Mehta S, Martin B, Wright D, Maizel A
Proc Natl Acad Sci U S A. 1984 Dec;81(24):7902-6. doi: 10.1073/pnas.81.24.7902.
Human B-cell growth factor has been described as a trypsin-sensitive protein of Mr 12,000-14,000. Evidence is provided herein that this relatively low molecular weight product may be released from a larger precursor molecule of Mr 60,000-80,000. The precursor protein is confined to the cytosol of freshly isolated T lymphocytes, and only the Mr 12,000-14,000 moiety is released upon lectin stimulation. The precursor protein was subjected to limited tryptic digestion, which demonstrated that the biologically active fraction of the moiety resided in a relatively low molecular weight fragment. The T lymphocyte routinely possessed an intracytoplasmic pool of the precursor protein, the amount of which cyclically varied depending upon its depletion by the secretion process of a lower molecular weight product. Analysis of the mRNA size coding for the majority of B-cell growth factor activity, determined by translation in Xenopus laevis oocytes, suggested that the B-cell growth factor-specific mRNA resided in the greater than or equal to 15S range. This value is consistent with the size of the larger precursor. Therefore, it is proposed that a precursor-product relationship exists for the processing of human B-cell growth factor, analogous to that which has been described for several other cytokines.
人B细胞生长因子被描述为一种分子量为12,000 - 14,000的对胰蛋白酶敏感的蛋白质。本文提供的证据表明,这种相对低分子量的产物可能是从分子量为60,000 - 80,000的较大前体分子释放而来。前体蛋白局限于新鲜分离的T淋巴细胞的胞质溶胶中,只有分子量为12,000 - 14,000的部分在凝集素刺激后释放。对前体蛋白进行了有限的胰蛋白酶消化,结果表明该部分的生物活性部分存在于相对低分子量的片段中。T淋巴细胞通常拥有前体蛋白的胞质内池,其数量会根据较低分子量产物的分泌过程导致的消耗而周期性变化。通过在非洲爪蟾卵母细胞中翻译来确定编码大部分B细胞生长因子活性的mRNA大小的分析表明,B细胞生长因子特异性mRNA存在于大于或等于15S的范围内。该值与较大前体的大小一致。因此,有人提出,人B细胞生长因子的加工存在前体-产物关系,类似于已描述的其他几种细胞因子的情况。